tanshinone has been researched along with Postoperative Complications in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hou, L; Li, X; Meng, X; Qin, F; Wang, C; Zhou, J | 1 |
Hou, C; Hou, L; Li, X; Lin, S; Ma, Y; Qin, F; Wang, C; Wang, X; Wei, Y | 1 |
2 other study(ies) available for tanshinone and Postoperative Complications
Article | Year |
---|---|
Prevention of experimental postoperative peritoneal adhesions through the intraperitoneal administration of tanshinone IIA.
Topics: Abietanes; Animals; Cecum; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Fibrinolytic Agents; Injections, Intraperitoneal; Male; Peritoneum; Phytotherapy; Plant Extracts; Plasminogen Inactivators; Postoperative Complications; Rats, Wistar; RNA, Messenger; Salvia miltiorrhiza; Tissue Adhesions; Tissue Plasminogen Activator | 2014 |
Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro.
Topics: Abietanes; Administration, Intravenous; Animals; Enzyme-Linked Immunosorbent Assay; Fibrinolysis; Male; Mice, Inbred BALB C; Nanoparticles; Peritoneal Diseases; Plasminogen Activator Inhibitor 1; Postoperative Complications; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Tissue Adhesions; Tissue Plasminogen Activator; Transforming Growth Factor beta1 | 2015 |